ReviewDiabetes & metabolism journal2015

Dipeptidyl Peptidase 4 Inhibitors and the Risk of Cardiovascular Disease in Patients with Type 2 Diabetes: A Tale of Three Studies.

Jang Won Son et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.